Montpellier, France

Catherine Cazaubon


Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1984-1988

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Catherine Cazaubon

Introduction

Catherine Cazaubon is a notable inventor based in Montpellier, France. She has made significant contributions to the field of biochemistry, particularly through her work on peptide derivatives. With a total of three patents to her name, Cazaubon has focused on innovations that have the potential to impact medical treatments.

Latest Patents

Cazaubon's latest patents include groundbreaking inventions related to peptide derivatives that inhibit renin and acid proteases. The first patent describes peptide derivatives modeled on the basis of pepstatin, which effectively inhibit renin and acid proteases. The second patent focuses on pepstatin analogs that also inhibit renin and acid proteases, making them particularly suitable for the treatment of arterial tension. These innovations highlight her commitment to advancing medical science through her research.

Career Highlights

Throughout her career, Cazaubon has worked with prominent organizations such as Sanofi and the Institut National de la Santé et de la Recherche Médicale. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Cazaubon has collaborated with notable colleagues, including Jean-Pierre Gagnol and Jean Wagnon. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Catherine Cazaubon is a pioneering inventor whose work on peptide derivatives has the potential to transform medical treatments. Her contributions to the field of biochemistry are commendable and reflect her dedication to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…